Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against Encompass Health Corporation for possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The investigation is prompted by allegations from a New York Times article published on July 15, 2025, which stated that Encompass's for-profit hospitals perform below average on key safety measures [6] - The article highlighted that Encompass owns 34 facilities rated by Medicare as having statistically significantly worse rates of potentially preventable readmissions, indicating serious operational issues [6] Stock Impact - Following the publication of the article, Encompass's stock price dropped by $12.39, or 10.4%, closing at $107.28 per share on July 15, 2025, resulting in financial losses for investors [6]
ENCOMPASS (EHC) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm